Cabinet Barny advised ILTOO PHARMA on the conclusion of a license option agreement with Servier for the clinical development and commercialization of the ILT-101 drug candidate for the treatment of autoimmune ...

Our Independence at the service of pioneers Cabinet BARNY is an independent law office which provides a fully integrated service in the field of innovation, especially in life science (pharmacy, biotechnology, ...

... issues in distribution agreement related to pharmaceutical products.  ...

We have a solid experience in the counsel of corporations in the field of pharmacy and biotechnologies and we had the opportunity to participate in many negotiations and drafting of manufacturing agreements ...

We know the issues regarding the negotiation and drafting of commercial agreements for corporations of all sizes, particularly in the field of pharmacy and biotechnologies. Our many years of practical ...

Cabinet Barny advised MedDay on the conclusion of a collaboration agreement with DSM to produce pharmaceutical grade D-biotin to treat progressive multiple sclerosis. ...

Cabinet Barny advised Enyo Pharma on the conclusion of a licence agreement with Poxel on Poxel’s FXR Agonists Program. ...

Cabinet Barny advised Kaldi Pharma, a subsidiary company of Domain Therapeutics, on the grant from Kaldi Pharma to Clevexel of a license to develop a potential preclinical drug candidate in Parkinson’s ...

Cabinet Barny advised GamaMabs Pharma on the conclusion of a collaboration agreement with Mayo Clinic on the study on the efficacy of one of GamaMabs Pharma’s monoclonal antibody in ovarian cancer. ...